Fundz

Nimble Therapeutics, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEApr 11, 2019

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Apr 11, 2019)

Round Type

Venture

MadisonBiotechnologyTherapeutics

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Nimble Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at Nimble Therapeutics, and when

A new round usually means Nimble Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nimble Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nimble Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nimble Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nimble Therapeutics

Location

500 South Rosa Road

Madison, Wisconsin, United States

About

Nimble is a biotechnology company dedicated to delivering on the promise of peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nimble Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Nimble Therapeutics's next move

See what Strategic adds

Nimble Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.